A detailed history of Barry Investment Advisors, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Barry Investment Advisors, LLC holds 1,955 shares of ABBV stock, worth $343,258. This represents 0.12% of its overall portfolio holdings.

Number of Shares
1,955
Previous 2,038 4.07%
Holding current value
$343,258
Previous $349,000 10.6%
% of portfolio
0.12%
Previous 0.12%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

SELL
$163.84 - $199.33 $13,598 - $16,544
-83 Reduced 4.07%
1,955 $386,000
Q2 2024

Aug 14, 2024

BUY
$154.79 - $180.76 $464 - $542
3 Added 0.15%
2,038 $349,000
Q1 2024

Apr 17, 2024

BUY
$159.82 - $182.1 $319 - $364
2 Added 0.1%
2,035 $370,000
Q4 2023

Feb 09, 2024

SELL
$137.6 - $154.97 $963 - $1,084
-7 Reduced 0.34%
2,033 $315,000
Q3 2023

Nov 13, 2023

BUY
$133.59 - $154.65 $267 - $309
2 Added 0.1%
2,040 $304,000
Q2 2023

Aug 02, 2023

SELL
$132.51 - $164.9 $6,890 - $8,574
-52 Reduced 2.49%
2,038 $274,000
Q1 2023

Apr 27, 2023

BUY
$144.61 - $166.54 $289 - $333
2 Added 0.1%
2,090 $333,000
Q4 2022

Jan 25, 2023

BUY
$138.31 - $165.87 $2,351 - $2,819
17 Added 0.82%
2,088 $0
Q3 2022

Oct 24, 2022

SELL
$134.21 - $153.93 $7,784 - $8,927
-58 Reduced 2.72%
2,071 $278,000
Q2 2022

Jul 27, 2022

SELL
$137.62 - $174.96 $56,561 - $71,908
-411 Reduced 16.18%
2,129 $326,000
Q1 2022

May 10, 2022

BUY
$131.98 - $163.75 $15,573 - $19,322
118 Added 4.87%
2,540 $412,000
Q4 2021

Feb 14, 2022

BUY
$107.43 - $135.93 $260,195 - $329,222
2,422 New
2,422 $328,000
Q3 2021

Oct 29, 2021

SELL
$106.4 - $120.78 $197,584 - $224,288
-1,857 Closed
0 $0
Q2 2021

Jul 29, 2021

BUY
$105.21 - $117.21 $195,374 - $217,658
1,857 New
1,857 $209,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $310B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Barry Investment Advisors, LLC Portfolio

Follow Barry Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barry Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Barry Investment Advisors, LLC with notifications on news.